{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-11T09:11:10.070772+00:00","company":{"ticker":"JYNT","cik":1612630,"company_name":"JOINT Corp"},"pagination":{"limit":100,"returned":40,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"Addisco Value, LLC, Triangle Chiropractic Associates P.C., Bluffton TJ, LLC, Alex Klaus, Todd Wegerski, DC, Lisa Ezell, Andrew Michael Evec, Susan Ruth Train","detail":"asset_purchase","count":1,"first_seen":"2025-12-11T23:59:59+00:00","last_seen":"2025-12-11T23:59:59+00:00","evidence_fact_ids":[128151]},{"display_name":"Bandera Partners LLC and Jefferson Gramm","detail":"other","count":1,"first_seen":"2026-01-09T23:59:59+00:00","last_seen":"2026-01-09T23:59:59+00:00","evidence_fact_ids":[35883]},{"display_name":"Bandera Partners LLC and certain of its affiliates","detail":"other","count":1,"first_seen":"2023-11-08T23:59:59+00:00","last_seen":"2023-11-08T23:59:59+00:00","evidence_fact_ids":[96874]},{"display_name":"Elite Chiro Group","detail":"asset_purchase","count":1,"first_seen":"2026-04-24T23:59:59+00:00","last_seen":"2026-04-24T23:59:59+00:00","evidence_fact_ids":[23180]},{"display_name":"Elite Chiro Group, Gadi Emein","detail":"asset_purchase","count":1,"first_seen":"2025-12-11T23:59:59+00:00","last_seen":"2025-12-11T23:59:59+00:00","evidence_fact_ids":[128152]}],"lender":[{"display_name":"JPMorgan Chase Bank, N.A.","detail":"revolving_credit","count":2,"first_seen":"2023-09-12T23:59:59+00:00","last_seen":"2026-05-07T23:59:59+00:00","evidence_fact_ids":[28476,114155]}],"ma_counterparty":[{"display_name":"Joint Ventures, LLC","detail":"disposition","count":1,"first_seen":"2025-07-07T23:59:59+00:00","last_seen":"2025-07-07T23:59:59+00:00","evidence_fact_ids":[28249]}]},"facts":[{"fact_type":"shareholder_vote","fact_key":"c6ea1cee7ed9ff71b85a7a174df4ee1bcad03606","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2026-05-21T20:32:11+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-20","outcome":"passed","proposal_text":"Ratification of BDO USA, P.C. as independent registered public accounting firm for 2026","proposal_type":"auditor_ratification","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"1,910","votes_against":"9,364","votes_for":"12,716,958","votes_withheld":null}]},"claim":"JOINT Corp shareholders approved Ratification of BDO USA, P.C. as independent registered public accounting firm for 2026 at the 2026-05-20 meeting.","evidence_excerpt":"Proposal 4. The ratification of the appointment of BDO USA, P.C. as our independent registered public accounting firm for the year ending December 31, 2026.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001612630-26-000054","anchor_url":"https://secwatch.observer/filing/0001612630-26-000054#claim-c6ea1cee7ed9ff71b85a7a174df4ee1bcad03606","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000054/0001612630-26-000054-index.htm"},{"fact_type":"shareholder_vote","fact_key":"51fe2d7640b6a7e99698cc2a84379269a2967480","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2026-05-21T20:32:11+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-20","outcome":"passed","proposal_text":"Advisory vote on frequency of say-on-pay","proposal_type":"say_on_pay_frequency","results":[{"broker_non_votes":"1,869,918","subject":null,"votes_abstain":"4,787","votes_against":null,"votes_for":"10,377,647","votes_withheld":null}]},"claim":"JOINT Corp shareholders approved Advisory vote on frequency of say-on-pay at the 2026-05-20 meeting.","evidence_excerpt":"Proposal 3. The approval, on an advisory basis, of the frequency of an advisory vote on the compensation of our named executive officers.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001612630-26-000054","anchor_url":"https://secwatch.observer/filing/0001612630-26-000054#claim-51fe2d7640b6a7e99698cc2a84379269a2967480","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000054/0001612630-26-000054-index.htm"},{"fact_type":"shareholder_vote","fact_key":"92920b2f09ab5a10d74117543d6627a335d47e06","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2026-05-21T20:32:11+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-20","outcome":"passed","proposal_text":"Advisory approval of named executive officer compensation","proposal_type":"say_on_pay","results":[{"broker_non_votes":"1,869,918","subject":null,"votes_abstain":"3,625","votes_against":"342,867","votes_for":"10,511,822","votes_withheld":null}]},"claim":"JOINT Corp shareholders approved Advisory approval of named executive officer compensation at the 2026-05-20 meeting.","evidence_excerpt":"Proposal 2. The approval, on an advisory basis, of the compensation of our named executive officers.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001612630-26-000054","anchor_url":"https://secwatch.observer/filing/0001612630-26-000054#claim-92920b2f09ab5a10d74117543d6627a335d47e06","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000054/0001612630-26-000054-index.htm"},{"fact_type":"shareholder_vote","fact_key":"602ac3baab9d0e90df4b01451e338ad238c273a3","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2026-05-21T20:32:11+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-20","outcome":"passed","proposal_text":"Election of seven nominees for director to serve until 2027 annual meeting","proposal_type":"director_election","results":[{"broker_non_votes":"1,869,918","subject":"Matthew E. Rubel","votes_abstain":"4,691","votes_against":null,"votes_for":"9,883,056","votes_withheld":"970,567"},{"broker_non_votes":"1,869,918","subject":"Ronald V. DaVella","votes_abstain":"4,691","votes_against":null,"votes_for":"10,104,633","votes_withheld":"748,990"},{"broker_non_votes":"1,869,918","subject":"Jefferson Gramm","votes_abstain":"4,692","votes_against":null,"votes_for":"10,781,916","votes_withheld":"71,706"},{"broker_non_votes":"1,869,918","subject":"Christopher M. Grandpre","votes_abstain":"4,691","votes_against":null,"votes_for":"10,198,649","votes_withheld":"654,974"},{"broker_non_votes":"1,869,918","subject":"Sandra R.A. Karrmann","votes_abstain":"4,601","votes_against":null,"votes_for":"10,223,126","votes_withheld":"630,587"},{"broker_non_votes":"1,869,918","subject":"Milind Pant","votes_abstain":"59,562","votes_against":null,"votes_for":"10,172,880","votes_withheld":"625,872"},{"broker_non_votes":"1,869,918","subject":"Sanjiv Razdan","votes_abstain":"3,558","votes_against":null,"votes_for":"10,809,749","votes_withheld":"45,007"}]},"claim":"JOINT Corp shareholders approved Election of seven nominees for director to serve until 2027 annual meeting at the 2026-05-20 meeting.","evidence_excerpt":"Proposal 1. The election to our Board of Directors of seven nominees for director to serve for the term expiring on the date of the next annual meeting of stockholders in 2027 or until his or her successors are elected and qualified.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001612630-26-000054","anchor_url":"https://secwatch.observer/filing/0001612630-26-000054#claim-602ac3baab9d0e90df4b01451e338ad238c273a3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000054/0001612630-26-000054-index.htm"},{"fact_type":"debt_financing","fact_key":"f7c5b8cfcb3501422ee7259487d0680e4f404901","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2026-05-07T23:59:59+00:00","payload":{"counterparty":"JPMorgan Chase Bank, N.A.","effective_date":"2026-05-01","event":"amendment","instrument_type":"revolving_credit","interest_rate_text":null,"item_codes_triggered":["2.03"],"maturity_text":"August 31, 2029","principal_text":null},"claim":"JOINT Corp amended revolving credit with JPMorgan Chase Bank, N.A. maturing August 31, 2029.","evidence_excerpt":"waiver and fourth amendment to our existing credit agreement (the “2026 Amendment”) with JPMorgan Chase Bank, N.A., individually and as Administrative Agent, Issuing Bank, and Lender (“JPMorgan Chase” or the “Lender”). Among other things, the 2026 Amendment waives the existing default of our credit facilities due to a violation of our fixed charge coverage ratio covenant, modifies the fixed charge coverage ratio covenant to allow for stock repurchases, which constitute restricted payments, and extends the revolving credit maturity date to August 31, 2029.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001612630-26-000048","anchor_url":"https://secwatch.observer/filing/0001612630-26-000048#claim-f7c5b8cfcb3501422ee7259487d0680e4f404901","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000048/0001612630-26-000048-index.htm"},{"fact_type":"earnings_release","fact_key":"d23ce1236b83e5512557bb3e383e8f7243e051aa","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2026-05-07T23:59:59+00:00","payload":{"eps_text":"$0.09 per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$1.3 million","period_text":"the first quarter ended March 31, 2026","report_date":"2026-05-07","result_type":"reported_results","revenue_text":"$14.8 million"},"claim":"JOINT Corp reported the first quarter ended March 31, 2026 results: revenue $14.8 million, net income $1.3 million, EPS $0.09 per diluted share.","evidence_excerpt":"first quarter ended March 31, 2026. The following figures represent continuing operations unless otherwise stated . First Quarter 2026 Financial Highlights • Grew revenues to $14.8 million, a 13% increase compared to the first quarter of 2025. • Reported system-wide sales 1 of $126.1 million, a decline of 4.9%. • Reported comp sales 2 of (4.2)%. • Net income from","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001612630-26-000048","anchor_url":"https://secwatch.observer/filing/0001612630-26-000048#claim-d23ce1236b83e5512557bb3e383e8f7243e051aa","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000048/0001612630-26-000048-index.htm"},{"fact_type":"material_agreement","fact_key":"60ef580505f8a4a85b426edf4c15ab1648efb04b","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2026-04-24T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Elite Chiro Group Purchase Agreement","agreement_type":"asset_purchase","counterparty":"Elite Chiro Group","effective_date":"2026-04-20","item_codes_triggered":["1.01"],"value_text":"$2.3 million"},"claim":"JOINT Corp entered into Elite Chiro Group Purchase Agreement with Elite Chiro Group valued at $2.3 million (effective 2026-04-20).","evidence_excerpt":"On April 20, 2026, we entered into an Asset Purchase Agreement (the “Elite Chiro Group Purchase Agreement”) with Elite Chiro Group, a California corporation (“Elite Chiro Group”), as buyer, and Gadi Emein, an individual (“Emein”), as guarantor, pursuant to which we will sell to Elite Chiro Group the assets of, and grant franchise rights to, 45 company-owned or managed clinics located in Southern California (the “Elite Chiro Group Transaction”) for an aggregate purchase price of $2.3 million, subject to certain adjustments (the “Purchase Price”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001612630-26-000036","anchor_url":"https://secwatch.observer/filing/0001612630-26-000036#claim-60ef580505f8a4a85b426edf4c15ab1648efb04b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000036/0001612630-26-000036-index.htm"},{"fact_type":"earnings_release","fact_key":"566fbf0b3076753b44c7db3586a2aabf005230d0","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2026-03-12T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$2.9 million","period_text":"the full year ended December 31, 2025","report_date":"2026-03-12","result_type":"reported_results","revenue_text":"$54.9 million"},"claim":"JOINT Corp reported the full year ended December 31, 2025 results: revenue $54.9 million, net income $2.9 million.","evidence_excerpt":"Full Year Revenues of $54.9 Million, Net Income of $2.9 Million and a 13.9% Increase in Adjusted EBITDA to $13.0 Million","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001612630-26-000018","anchor_url":"https://secwatch.observer/filing/0001612630-26-000018#claim-566fbf0b3076753b44c7db3586a2aabf005230d0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000018/0001612630-26-000018-index.htm"},{"fact_type":"earnings_release","fact_key":"83efebc7791861d173d1bb063ca5f355d65198cb","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2026-03-12T23:59:59+00:00","payload":{"eps_text":"$0.07 per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$1.0 million","period_text":"the fourth quarter ended December 31, 2025","report_date":"2026-03-12","result_type":"reported_results","revenue_text":"$15.2 million"},"claim":"JOINT Corp reported the fourth quarter ended December 31, 2025 results: revenue $15.2 million, net income $1.0 million, EPS $0.07 per diluted share.","evidence_excerpt":"Revenue increased 3.1% to $15.2 million, compared to $14.7 million in the fourth quarter of 2024.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001612630-26-000018","anchor_url":"https://secwatch.observer/filing/0001612630-26-000018#claim-83efebc7791861d173d1bb063ca5f355d65198cb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000018/0001612630-26-000018-index.htm"},{"fact_type":"material_agreement","fact_key":"7cfb65a6b1c211a5e3ec18b7c428ca9fdc1b64a2","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2026-01-09T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Letter Agreement","agreement_type":"other","counterparty":"Bandera Partners LLC and Jefferson Gramm","effective_date":"2026-01-05","item_codes_triggered":["1.01"],"value_text":"Company agrees to include Jefferson Gramm in its slate of nominees for the 2026 annual meeting and r"},"claim":"JOINT Corp entered into Letter Agreement with Bandera Partners LLC and Jefferson Gramm valued at Company agrees to include Jefferson Gramm in its slate of nominees for the 2026 annual meeting and r (effective 2026-01-05).","evidence_excerpt":"On January 5, 2026, we entered into a letter of agreement (the “Letter Agreement”) with Bandera Partners LLC and Jefferson Gramm (collectively, “Bandera”). Pursuant to the Letter Agreement, subject to certain conditions, we have agreed to include Mr. Gramm in our slate of nominees for the election of directors at our 2026 annual meeting of stockholders (the “2026 Annual Meeting”) and recommend that our stockholders vote in favor of his election at the 2026 Annual Meeting. The Letter Agreement also includes certain voting commitments and standstill obligations by Bandera as well as certain restrictions on the transfer of our common stock, par value $0.001 per share, held by Bandera until the Termination Date (as defined below).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001612630-26-000004","anchor_url":"https://secwatch.observer/filing/0001612630-26-000004#claim-7cfb65a6b1c211a5e3ec18b7c428ca9fdc1b64a2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000004/0001612630-26-000004-index.htm"},{"fact_type":"material_agreement","fact_key":"8e0cce1c0d91c33363025e8fdbb696b786a9e75a","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2025-12-11T23:59:59+00:00","payload":{"action":"termination","agreement_name":"Elite Chiro Group Purchase Agreement","agreement_type":"asset_purchase","counterparty":"Elite Chiro Group, Gadi Emein","effective_date":"2025-12-11","item_codes_triggered":["1.02"],"value_text":"$4.5 million"},"claim":"JOINT Corp terminated Elite Chiro Group Purchase Agreement with Elite Chiro Group, Gadi Emein valued at $4.5 million (effective 2025-12-11).","evidence_excerpt":"On December 11, 2025, we delivered a notice of termination (the “Elite Chiro Group Termination Notice”) to terminate the Asset Purchase Agreement, dated November 2, 2025 (the “Elite Chiro Group Purchase Agreement”), between us, Elite Chiro Group, a California corporation (“Elite Chiro Group”), as buyer, and Gadi Emein, an individual, as guarantor, pursuant to which we would have sold to Elite Chiro Group the assets of, and granted franchise rights to, 45 company-owned or managed clinics located in Southern California for an aggregate purchase price of $4.5 million, subject to certain adjustments.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001612630-25-000074","anchor_url":"https://secwatch.observer/filing/0001612630-25-000074#claim-8e0cce1c0d91c33363025e8fdbb696b786a9e75a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263025000074/0001612630-25-000074-index.htm"},{"fact_type":"material_agreement","fact_key":"3488f9cd5888a7affe910ba3693ff27b7d4fdcce","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2025-12-11T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Southeast Purchase Agreement","agreement_type":"asset_purchase","counterparty":"Addisco Value, LLC, Triangle Chiropractic Associates P.C., Bluffton TJ, LLC, Alex Klaus, Todd Wegerski, DC, Lisa Ezell, Andrew Michael Evec, Susan Ruth Train","effective_date":"2025-12-05","item_codes_triggered":["1.01"],"value_text":"$1,482,800"},"claim":"JOINT Corp entered into Southeast Purchase Agreement with Addisco Value, LLC, Triangle Chiropractic Associates P.C., Bluffton TJ, LLC, Alex Klaus, Todd Wegerski, DC, Lisa Ezell, Andrew Michael Evec, Susan Ruth Train valued at $1,482,800 (effective 2025-12-05).","evidence_excerpt":"On December 5, 2025, we entered into an Asset Purchase Agreement (as amended, the “Southeast Purchase Agreement”) with Addisco Value, LLC, a North Carolina limited liability company, Triangle Chiropractic Associates P.C., a North Carolina professional corporation, and Bluffton TJ, LLC, a South Carolina limited liability company (collectively, the “Buyers”), and Alex Klaus, an individual, Todd Wegerski, DC, an individual, Lisa Ezell, an individual, Andrew Michael Evec, an individual, and Susan Ruth Train, an individual (collectively, the “Guarantors”), pursuant to which we will sell to the Buyers the assets of, and grant franchise rights to, 22 company-owned or managed clinics located in Virginia, North Carolina and South Carolina (the “Southeast Transaction”) for an aggregate purchase price of $1,482,800, subject to certain adjustments (the “Purchase Price”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001612630-25-000074","anchor_url":"https://secwatch.observer/filing/0001612630-25-000074#claim-3488f9cd5888a7affe910ba3693ff27b7d4fdcce","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263025000074/0001612630-25-000074-index.htm"},{"fact_type":"ma_transaction","fact_key":"6ddd868aa36428951d2c2317e8f260ee55087b08","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2025-07-07T23:59:59+00:00","payload":{"action":"disposition","closing_date":"2025-06-30","consideration_text":"$11.13 million","counterparty":"Joint Ventures, LLC","effective_date":"2025-06-30","item_codes_triggered":["2.01"]},"claim":"JOINT Corp completed a disposition involving Joint Ventures, LLC for $11.13 million (closed 2025-06-30).","evidence_excerpt":"On June 30, 2025, we completed the previously announced sale of the assets of, and the franchise rights to, 31 company-owned and managed clinics located in Arizona and New Mexico (the “Joint Ventures Transaction”) to Joint Ventures, LLC, a Nevada limited liability company and our largest franchisee (“Joint Ventures”), for an aggregate purchase price of $11.13 million, subject to certain adjustments, pursuant to an Asset Purchase Agreement, dated as of June 23, 2025, by and between us and Joint Ventures.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001612630-25-000009","anchor_url":"https://secwatch.observer/filing/0001612630-25-000009#claim-6ddd868aa36428951d2c2317e8f260ee55087b08","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263025000009/0001612630-25-000009-index.htm"},{"fact_type":"executive_change","fact_key":"4859c7ca80","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2025-06-10T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-06-10","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":"Jake Singleton","successor_named":true},"claim":"Scott J. Bowman was appointed as Chief Financial Officer at JOINT Corp.","evidence_excerpt":"Effective June 10, 2025, our Board of Directors (the “Board”) appointed Scott J. Bowman as our Chief Financial Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-25-030452","anchor_url":"https://secwatch.observer/filing/0001628280-25-030452#claim-4859c7ca80","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000162828025030452/0001628280-25-030452-index.htm"},{"fact_type":"executive_change","fact_key":"102616c4dc","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2025-06-10T23:59:59+00:00","payload":{"action":"separated","action_category":"departure","departure_tone":"routine","effective_date":"2025-06-09","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":"Scott J. Bowman","successor_named":true},"claim":"Jake Singleton departed as Chief Financial Officer at JOINT Corp.","evidence_excerpt":"Effective June 9, 2025, Jake Singleton separated from our company as our Chief Financial Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-25-030452","anchor_url":"https://secwatch.observer/filing/0001628280-25-030452#claim-102616c4dc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000162828025030452/0001628280-25-030452-index.htm"},{"fact_type":"executive_change","fact_key":"71da3f41c7","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2025-06-05T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-06-03","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Sandra R.A. Karrmann was appointed as Director at JOINT Corp.","evidence_excerpt":"On June 3, 2025, our Board of Directors (the “Board”) increased the size of the Board by one director and appointed Sandra R.A. Karrmann to fill the vacancy created by the increase in size of the Board.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-25-029505","anchor_url":"https://secwatch.observer/filing/0001628280-25-029505#claim-71da3f41c7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000162828025029505/0001628280-25-029505-index.htm"},{"fact_type":"executive_change","fact_key":"0b429afb0d","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2024-10-15T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-10-14","interim":false,"role":"President and Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Sanjiv Razdan was appointed as President and Chief Executive Officer at JOINT Corp.","evidence_excerpt":"Effective October 14, 2024, the Board of Directors of the Company appointed Sanjiv Razdan as President and Chief Executive Officer of the Company and as a member of the Company’s Board of Directors.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001171843-24-005643","anchor_url":"https://secwatch.observer/filing/0001171843-24-005643#claim-0b429afb0d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184324005643/0001171843-24-005643-index.htm"},{"fact_type":"executive_change","fact_key":"43825454be","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2024-10-15T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-10-10","interim":false,"role":"President and Chief Executive Officer","role_category":"ceo","successor_name":"Sanjiv Razdan","successor_named":true},"claim":"Peter D. Holt resigned as President and Chief Executive Officer at JOINT Corp.","evidence_excerpt":"Effective October 10, 2024, Peter D. Holt resigned as President and Chief Executive Officer of The Joint Corp. (the “Company”) and as a member of the Company’s Board of Directors.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001171843-24-005643","anchor_url":"https://secwatch.observer/filing/0001171843-24-005643#claim-43825454be","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184324005643/0001171843-24-005643-index.htm"},{"fact_type":"earnings_release","fact_key":"7172e6b971275d651a698431415b70155c78c5ef","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2024-05-02T23:59:59+00:00","payload":{"eps_text":"$0.06 per diluted share","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":"$947,000","period_text":"Q1 2024","report_date":"2024-05-02","result_type":"reported_results","revenue_text":"$29.7 million"},"claim":"JOINT Corp reported Q1 2024 results: revenue $29.7 million, net income $947,000, EPS $0.06 per diluted share. Guidance reaffirmed.","evidence_excerpt":"franchisor of chiropractic clinics, reported its financial results for the quarter ended March 31, 2024. Financial Highlights: Q1 2024 Compared to Q1 2023 • Grew revenue 5% to $29.7 million. • Recorded operating income of $1.1 million, compared to operating loss of $653,000. • Reported net income of $947,000, compared to $2.3 million, including the receipt of the","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001612630-24-000003","anchor_url":"https://secwatch.observer/filing/0001612630-24-000003#claim-7172e6b971275d651a698431415b70155c78c5ef","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263024000003/0001612630-24-000003-index.htm"},{"fact_type":"earnings_release","fact_key":"26b487a5069b6ae6c38e1e33721729e703b62cc2","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2024-03-07T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the quarter and year ended December 31, 2023","report_date":"2024-03-07","result_type":"reported_results","revenue_text":null},"claim":"JOINT Corp reported financial results for the quarter and year ended December 31, 2023.","evidence_excerpt":"On March 7, 2024, The Joint Corp. (the \"Company\") issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2023.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001171843-24-001235","anchor_url":"https://secwatch.observer/filing/0001171843-24-001235#claim-26b487a5069b6ae6c38e1e33721729e703b62cc2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184324001235/0001171843-24-001235-index.htm"},{"fact_type":"earnings_release","fact_key":"547fabf7c8d0ec0b65a219d046edce866c1c32b1","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-11-09T23:59:59+00:00","payload":{"eps_text":"$0.05 per share","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":"net loss of $716,000, or $0.05 per share","period_text":"the quarter ended September 30, 2023","report_date":"2023-11-09","result_type":"reported_results","revenue_text":"$29.5 million"},"claim":"JOINT Corp reported the quarter ended September 30, 2023 results: revenue $29.5 million, net income net loss of $716,000, or $0.05 per share, EPS $0.05 per share. Guidance reaffirmed.","evidence_excerpt":"of chiropractic clinics, reported its financial results for the quarter ended September 30, 2023. Financial Highlights: Q3 2023 Compared to Q3 2022 ● Grew revenue by 11% to $29.5 million. ● Reported operating loss of $898,000, compared to operating income of $732,000. ● Reported net loss of $716,000, including a loss on disposition or impairment related to","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001171843-23-006953","anchor_url":"https://secwatch.observer/filing/0001171843-23-006953#claim-547fabf7c8d0ec0b65a219d046edce866c1c32b1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323006953/0001171843-23-006953-index.htm"},{"fact_type":"material_agreement","fact_key":"6e4c84e864a99af15010e7134ab61d292aa5accb","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-11-08T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Nomination and Standstill Agreement","agreement_type":"other","counterparty":"Bandera Partners LLC and certain of its affiliates","effective_date":"2023-11-06","item_codes_triggered":["1.01"],"value_text":"appointment of Jefferson Gramm as director effective January 2, 2024; inclusion in slate for 2024 an"},"claim":"JOINT Corp entered into Nomination and Standstill Agreement with Bandera Partners LLC and certain of its affiliates valued at appointment of Jefferson Gramm as director effective January 2, 2024; inclusion in slate for 2024 an (effective 2023-11-06).","evidence_excerpt":"On November 6, 2023, The Joint Corp. (the “ Company ”) entered into a Nomination and Standstill Agreement (the “ Nomination and Standstill Agreement ”) with Bandera Partners LLC and certain of its affiliates (collectively, “ Bandera ”) regarding the membership and composition of the Company’s board of directors (the “ Board ”) and related matters.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-23-037571","anchor_url":"https://secwatch.observer/filing/0001628280-23-037571#claim-6e4c84e864a99af15010e7134ab61d292aa5accb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000162828023037571/0001628280-23-037571-index.htm"},{"fact_type":"executive_change","fact_key":"aaa8f429f3","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-11-08T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-02","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Jeff Gramm was appointed as Director at JOINT Corp.","evidence_excerpt":"the Board agreed to appoint Mr. Gramm to the Board effective as of January 2, 2024","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-23-037571","anchor_url":"https://secwatch.observer/filing/0001628280-23-037571#claim-aaa8f429f3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000162828023037571/0001628280-23-037571-index.htm"},{"fact_type":"auditor_change","fact_key":"12ffa93612c5e3e7fa8ab82c39914d241918dbca","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-09-15T23:59:59+00:00","payload":{"action":"non_reliance","auditor_name":"BDO USA, P.C.","disagreement_text":null,"effective_date":null,"item_codes_triggered":["4.02"],"non_reliance_signal":"restatement","successor_auditor_name":null},"claim":"JOINT Corp reported that prior financial statements should not be relied upon.","evidence_excerpt":"embers of the Audit Committee to discuss the matters disclosed in this Item 4.02 and in consultation with BDO USA, P.C. (“BDO”),\nthe Company’s independent registered public accounting firm, concluded that the Company’s previously issued audited financial\nstatements as of and for the year ending December 31, 2022 contained in the Annual Report on Form 10-K for the year ended December 31,\n2022 and the unaudited interim financial statements contained in the Quarterly Reports on Form 10-Q for the quarters and cumulative periods\nended June 30, 2022, and September 30, 2022 (the “2022 Previously Issued Financial Statements”) contained material errors\nand should be restated, which the conclusion was thereafter formally ratified by the Audit Committee and the Board of Directors of the\nCompany. This determination occurred following discussions of the matter among BDO, officers of the Company and m","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001171843-23-005715","anchor_url":"https://secwatch.observer/filing/0001171843-23-005715#claim-12ffa93612c5e3e7fa8ab82c39914d241918dbca","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323005715/0001171843-23-005715-index.htm"},{"fact_type":"earnings_release","fact_key":"da7e907416ac17907eba3f9d3a83d9f20917ee02","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-09-13T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"lowered","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the second quarter ended June 30, 2023","report_date":"2023-09-13","result_type":"preliminary_results","revenue_text":"$29.3 million"},"claim":"JOINT Corp reported the second quarter ended June 30, 2023 results: revenue $29.3 million. Guidance lowered.","evidence_excerpt":"its preliminary financial results for the second quarter ended June 30, 2023. Preliminary Financial Highlights: Q2 2023 Compared to Q2 2022 Grew preliminary revenue 18% to $29.3 million. Reported preliminary operating loss of $375,000, compared to $1.3 million. Reported preliminary loss before income tax expense of $481,000, compared to $1.3 million. Increased","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001171843-23-005696","anchor_url":"https://secwatch.observer/filing/0001171843-23-005696#claim-da7e907416ac17907eba3f9d3a83d9f20917ee02","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323005696/0001171843-23-005696-index.htm"},{"fact_type":"debt_financing","fact_key":"31b8e6b632053e199618e63016708c4d14363e40","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-09-12T23:59:59+00:00","payload":{"counterparty":"JPMorgan Chase Bank, N.A.","effective_date":"2023-09-08","event":"amendment","instrument_type":"revolving_credit","interest_rate_text":"increase the rate of interest applicable to the outstanding loans and other obli","item_codes_triggered":["2.04"],"maturity_text":"2027-02-28","principal_text":"$20,000,000"},"claim":"JOINT Corp amended revolving credit of $20,000,000 with JPMorgan Chase Bank, N.A. at increase the rate of interest applicable to the outstanding loans and other obli maturing 2027-02-28.","evidence_excerpt":"10-Q on or before September 30,\n2023, will constitute an immediate default. Under the Credit Agreement, the Company’s senior secured revolving\nline of credit (the “Revolver”) is $20,000,000, the portion of the Revolver available for letters of credit is $5,000,000\nand the uncommitted additional line of credit is $30,000,000 (collectively, the “2022 Credit","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001171843-23-005680","anchor_url":"https://secwatch.observer/filing/0001171843-23-005680#claim-31b8e6b632053e199618e63016708c4d14363e40","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323005680/0001171843-23-005680-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"d74c48f19bd4df2b4d4949065fa956da9b5b9789","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-08-25T23:59:59+00:00","payload":{"company_response":"will work diligently to file the Form 10-Q and submit a plan of compliance","compliance_status":"deficient","cure_deadline":"2023-10-23","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2023-08-22","notice_type":"noncompliance_notice","plan_due_date":"2023-10-23","raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"JOINT Corp received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"August 22, 2023, The Joint Corp. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under the Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of the Company’s failure to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “Form 10-Q”) with the United States Securities and Exchange Commission (the “SEC”) in a timely manner, which deadline was August 21, 2023 (as a result of the Comp","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001171843-23-005436","anchor_url":"https://secwatch.observer/filing/0001171843-23-005436#claim-d74c48f19bd4df2b4d4949065fa956da9b5b9789","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323005436/0001171843-23-005436-index.htm"},{"fact_type":"earnings_release","fact_key":"1bba1bea0edc22d6f2f748d39266fd8a86ceb464","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-08-10T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the quarter ended June 30, 2023","report_date":"2023-08-10","result_type":"preliminary_results","revenue_text":null},"claim":"JOINT Corp reported preliminary financial results for the quarter ended June 30, 2023.","evidence_excerpt":"The Joint Corp. (the “Company”) issued a press release announcing its preliminary financial results for the quarter ended June 30, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001171843-23-005230","anchor_url":"https://secwatch.observer/filing/0001171843-23-005230#claim-1bba1bea0edc22d6f2f748d39266fd8a86ceb464","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323005230/0001171843-23-005230-index.htm"},{"fact_type":"shareholder_vote","fact_key":"a9c1d0f3d55cde8040c5f9ba9035828bb7054e3d","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-05-26T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-25","outcome":"passed","proposal_text":"The ratification of the selection of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.","proposal_type":"auditor_ratification","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"20,118","votes_against":"69,936","votes_for":"11,451,970","votes_withheld":"0"}]},"claim":"JOINT Corp shareholders approved The ratification of the selection of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-05-25 meeting.","evidence_excerpt":"Proposal 4. The ratification of the selection of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. In accordance with the results below, the selection of BDO USA, LLP was ratified. Votes For Votes Against Abstentions 11,451,970 69,936 20,118","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001171843-23-003582","anchor_url":"https://secwatch.observer/filing/0001171843-23-003582#claim-a9c1d0f3d55cde8040c5f9ba9035828bb7054e3d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323003582/0001171843-23-003582-index.htm"},{"fact_type":"shareholder_vote","fact_key":"b8a0928ca29030b01677c9c99608705a60336956","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-05-26T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-25","outcome":"passed","proposal_text":"The approval of an amendment to the Company’s Amended and Restated 2014 Incentive Stock Plan, as amended, to increase the number of shares reserved for issuance under the plan by 1,200,000 shares, for a total of 3,413,000 authorized shares.","proposal_type":"equity_plan","results":[{"broker_non_votes":"1,830,251","subject":null,"votes_abstain":"2,503","votes_against":"603,264","votes_for":"9,106,006","votes_withheld":"0"}]},"claim":"JOINT Corp shareholders approved The approval of an amendment to the Company’s Amended and Restated 2014 Incentive Stock Plan, as amended, to increase the number of shares reserved for issuance under the plan by 1,200,000 shares, for a total of 3,413,000 authorized shares. at the 2023-05-25 meeting.","evidence_excerpt":"Proposal 3. The approval of an amendment to the Company’s Amended and Restated 2014 Incentive Stock Plan, as amended, to increase the number of shares reserved for issuance under the plan by 1,200,000 shares, for a total of 3,413,000 authorized shares. Votes For Votes Against Abstentions Broker Non-Votes 9,106,006 603,264 2,503 1,830,251","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001171843-23-003582","anchor_url":"https://secwatch.observer/filing/0001171843-23-003582#claim-b8a0928ca29030b01677c9c99608705a60336956","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323003582/0001171843-23-003582-index.htm"},{"fact_type":"shareholder_vote","fact_key":"3e96195dbb9702c2a714c675a9b22447a9f33e5e","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-05-26T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-25","outcome":"passed","proposal_text":"The approval, on a non-binding advisory basis, of the compensation of the named executive officers as disclosed pursuant to Item 402 of Regulation S-K in the Company’s Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 21, 2023, for the 2023 ann","proposal_type":"say_on_pay","results":[{"broker_non_votes":"1,830,251","subject":null,"votes_abstain":"3,363","votes_against":"258,742","votes_for":"9,449,668","votes_withheld":"0"}]},"claim":"JOINT Corp shareholders approved The approval, on a non-binding advisory basis, of the compensation of the named executive officers as disclosed pursuant to Item 402 of Regulation S-K in the Company’s Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 21, 2023, for the 2023 ann at the 2023-05-25 meeting.","evidence_excerpt":"Proposal 2. The approval, on a non-binding advisory basis, of the compensation of the named executive officers as disclosed pursuant to Item 402 of Regulation S-K in the Company’s Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 21, 2023, for the 2023 annual meeting of stockholders. In accordance with the results below, the proposed resolution was approved. Votes For Votes Against Abstentions Broker Non-Votes 9,449,668 258,742 3,363 1,830,251","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001171843-23-003582","anchor_url":"https://secwatch.observer/filing/0001171843-23-003582#claim-3e96195dbb9702c2a714c675a9b22447a9f33e5e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323003582/0001171843-23-003582-index.htm"},{"fact_type":"shareholder_vote","fact_key":"24090280ccd655e790662d11ebdc8acb494fcf1c","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-05-26T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-25","outcome":"passed","proposal_text":"The election of six members of the Company’s board of directors for terms expiring at the 2024 annual meeting of stockholders.","proposal_type":"director_election","results":[{"broker_non_votes":"1,830,251","subject":"Matthew E. Rubel","votes_abstain":"1,082","votes_against":"633,557","votes_for":"9,077,134","votes_withheld":"0"},{"broker_non_votes":"1,830,251","subject":"Ronald V. DaVella","votes_abstain":"1,082","votes_against":"3,817,725","votes_for":"5,892,966","votes_withheld":"0"},{"broker_non_votes":"1,830,251","subject":"Suzanne M. Decker","votes_abstain":"1,179","votes_against":"309,700","votes_for":"9,400,894","votes_withheld":"0"},{"broker_non_votes":"1,830,251","subject":"Peter D. Holt","votes_abstain":"2,499","votes_against":"125,548","votes_for":"9,583,726","votes_withheld":"0"},{"broker_non_votes":"1,830,251","subject":"Abe Hong","votes_abstain":"1,083","votes_against":"310,094","votes_for":"9,400,596","votes_withheld":"0"},{"broker_non_votes":"1,830,251","subject":"Glenn J. Krevlin","votes_abstain":"1,863","votes_against":"315,790","votes_for":"9,394,120","votes_withheld":"0"}]},"claim":"JOINT Corp shareholders approved The election of six members of the Company’s board of directors for terms expiring at the 2024 annual meeting of stockholders. at the 2023-05-25 meeting.","evidence_excerpt":"Proposal 1. The election of six members of the Company’s board of directors for terms expiring at the 2024 annual meeting of stockholders. In accordance with the results below, each nominee was elected to serve as a director. Votes For Votes Against Abstentions Broker Non-Votes Matthew E. Rubel 9,077,134 633,557 1,082 1,830,251 Ronald V. DaVella 5,892,966 3,817,725 1,082 1,830,251 Suzanne M. Decker 9,400,894 309,700 1,179 1,830,251 Peter D. Holt 9,583,726 125,548 2,499 1,830,251 Abe Hong 9,400,596 310,094 1,083 1,830,251 Glenn J. Krevlin 9,394,120 315,790 1,863 1,830,251","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001171843-23-003582","anchor_url":"https://secwatch.observer/filing/0001171843-23-003582#claim-24090280ccd655e790662d11ebdc8acb494fcf1c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323003582/0001171843-23-003582-index.htm"},{"fact_type":"earnings_release","fact_key":"e7673b139ec816ecfdd7d14d6821b8d08ecbe647","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-05-04T23:59:59+00:00","payload":{"eps_text":"$0.15 per diluted share","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":"$2.3 million","period_text":"the quarter ended March 31, 2023","report_date":"2023-05-04","result_type":"reported_results","revenue_text":"$28.5 million"},"claim":"JOINT Corp reported the quarter ended March 31, 2023 results: revenue $28.5 million, net income $2.3 million, EPS $0.15 per diluted share. Guidance reaffirmed.","evidence_excerpt":"franchisor of chiropractic clinics, reported its financial results for the quarter ended March 31, 2023. Financial Highlights: Q1 2023 Compared to Q1 2022 Grew revenue 27% to $28.5 million. Reported operating loss of $678,000, compared to a loss of $176,000. Reported net income of $2.3 million, including $3.9 million of employee retention credits, compared to a net","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001171843-23-002890","anchor_url":"https://secwatch.observer/filing/0001171843-23-002890#claim-e7673b139ec816ecfdd7d14d6821b8d08ecbe647","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323002890/0001171843-23-002890-index.htm"},{"fact_type":"governance_change","fact_key":"e2f9b0943832bc8c185a8cbe7143192b635b2ee0","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-04-26T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2023-04-20","item_codes_triggered":["5.03"],"summary_text":"The Board of Directors amended and restated the bylaws to update provisions regarding annual meetings, proxy access, voting list, and adjournments in light of recent changes to Delaware General Corporation Law and SEC universal proxy rules."},"claim":"JOINT Corp: The Board of Directors amended and restated the bylaws to update provisions regarding annual meetings, proxy access, voting list, and adjournments in light of recent changes to Delaware General Corporation Law and SEC universal proxy rules (effective 2023-04-20).","evidence_excerpt":"On April 20, 2023, the Board of Directors of The Joint Corp. (the “Company”) approved certain amendments to, and the amendment and restatement of, the Company’s bylaws (the “Third Amended and Restated Bylaws”), which became effective the same day.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001171843-23-002585","anchor_url":"https://secwatch.observer/filing/0001171843-23-002585#claim-e2f9b0943832bc8c185a8cbe7143192b635b2ee0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323002585/0001171843-23-002585-index.htm"},{"fact_type":"executive_change","fact_key":"d9bec97fc7","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-03-13T23:59:59+00:00","payload":{"action":"not stand for reelection","action_category":"departure","departure_tone":"retirement","effective_date":"2023-05-25","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"James H. Amos, Jr. departed as Director at JOINT Corp.","evidence_excerpt":"On March 7, 2023, Mr. James H. Amos, Jr., a director of The Joint Corp. (the “Company”) notified the Company that he will not stand for reelection at the Company’s 2023 Annual Meeting of Stockholders.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001171843-23-001615","anchor_url":"https://secwatch.observer/filing/0001171843-23-001615#claim-d9bec97fc7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323001615/0001171843-23-001615-index.htm"},{"fact_type":"earnings_release","fact_key":"ab671b5b0105644d0a2f030446ae2f5e4496c510","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-03-09T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"initiated","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"2023","report_date":"2023-03-09","result_type":"guidance_update","revenue_text":"between $123.0 million and $128.0 million"},"claim":"JOINT Corp reported 2023 results: revenue between $123.0 million and $128.0 million. Guidance initiated.","evidence_excerpt":"Revenue is expected to be between $123.0 million and $128.0 million, compared to $101.9 million in 2022.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001171843-23-001550","anchor_url":"https://secwatch.observer/filing/0001171843-23-001550#claim-ab671b5b0105644d0a2f030446ae2f5e4496c510","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323001550/0001171843-23-001550-index.htm"},{"fact_type":"earnings_release","fact_key":"3c61c22cb67c9e771b41cd537259282b0f6d5e8b","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-03-09T23:59:59+00:00","payload":{"eps_text":"$0.08 per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$1.2 million","period_text":"year ended December 31, 2022","report_date":"2023-03-09","result_type":"reported_results","revenue_text":"$101.9 million"},"claim":"JOINT Corp reported year ended December 31, 2022 results: revenue $101.9 million, net income $1.2 million, EPS $0.08 per diluted share.","evidence_excerpt":"Revenue was $101.9 million in 2022, compared to $80.9 million in 2021.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001171843-23-001550","anchor_url":"https://secwatch.observer/filing/0001171843-23-001550#claim-3c61c22cb67c9e771b41cd537259282b0f6d5e8b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323001550/0001171843-23-001550-index.htm"},{"fact_type":"earnings_release","fact_key":"de00f3075ce4319fc50aac9f704d497bd4142d7a","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2023-03-09T23:59:59+00:00","payload":{"eps_text":"$0.04 per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$547,000","period_text":"fourth quarter ended December 31, 2022","report_date":"2023-03-09","result_type":"reported_results","revenue_text":"$27.8 million"},"claim":"JOINT Corp reported fourth quarter ended December 31, 2022 results: revenue $27.8 million, net income $547,000, EPS $0.04 per diluted share.","evidence_excerpt":"Revenue was $27.8 million in the fourth quarter of 2022, compared to $22.1 million in the fourth quarter of 2021.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001171843-23-001550","anchor_url":"https://secwatch.observer/filing/0001171843-23-001550#claim-de00f3075ce4319fc50aac9f704d497bd4142d7a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323001550/0001171843-23-001550-index.htm"},{"fact_type":"earnings_release","fact_key":"0934e0a0e549ca0a7906bd4525883ec82fa37fc2","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2022-11-03T23:59:59+00:00","payload":{"eps_text":"$0.04 per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$630,000","period_text":"the nine months ended September 30, 2022","report_date":"2022-11-03","result_type":"reported_results","revenue_text":"$74.1 million"},"claim":"JOINT Corp reported the nine months ended September 30, 2022 results: revenue $74.1 million, net income $630,000, EPS $0.04 per diluted share.","evidence_excerpt":"Revenue was $74.1 million in the first nine months of 2022, compared to $58.8 million in the first nine months of 2021. Net income was $630,000, or $0.04 per diluted share, compared to $6.9 million, or $0.46 per diluted share, in the first nine months of 2021.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001171843-22-007076","anchor_url":"https://secwatch.observer/filing/0001171843-22-007076#claim-0934e0a0e549ca0a7906bd4525883ec82fa37fc2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184322007076/0001171843-22-007076-index.htm"},{"fact_type":"earnings_release","fact_key":"4adeb5630c3d99b8f086b2ca96655be32ecf5ce1","cik":1612630,"ticker":"JYNT","company_name":"JOINT Corp","filed_at":"2022-11-03T23:59:59+00:00","payload":{"eps_text":"$0.03 per diluted share","guidance_signal":"unknown","item_codes_triggered":["2.02"],"net_income_text":"$491,000","period_text":"the quarter ended September 30, 2022","report_date":"2022-11-03","result_type":"reported_results","revenue_text":"$26.6 million"},"claim":"JOINT Corp reported the quarter ended September 30, 2022 results: revenue $26.6 million, net income $491,000, EPS $0.03 per diluted share.","evidence_excerpt":"Grew revenue 27% to $26.6 million. Recorded operating income of $500,000, compared to $1.3 million. Reported net income of $491,000, compared to $1.9 million.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001171843-22-007076","anchor_url":"https://secwatch.observer/filing/0001171843-22-007076#claim-4adeb5630c3d99b8f086b2ca96655be32ecf5ce1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184322007076/0001171843-22-007076-index.htm"}]}